Case Studies
Proven Results Across Healthcare & Life Sciences
Our case studies showcase transformative results delivered to leading medical device and pharmaceutical companies. Each engagement showcases our commitment to rigorous methodology, actionable insights, and strategic outcomes that drive real business value.
Infusion Pump Data Analytics & Safety Optimization
Client: Fortune 500 Medical Device Company
Challenge: Analyze comprehensive infusion pump usage data to understand operational patterns, safety performance, and EHR integration impact across diverse healthcare settings.
Our Approach:
Processed and analyzed over 3 billion rows of infusion pump data using advanced big data techniques
Stratified analysis by care area to identify usage patterns and performance variations
Compared integrated EHR systems versus manual (non-integrated) processes for operational efficiency
Conducted comprehensive medication analysis including infusion counts, error rates, and safety protocols
Results:
Identified top medications by infusion volume and usage patterns across different hospital systems
Quantified medication error rates and safety protocol effectiveness to inform quality improvements
Analyzed high-risk medication patterns and regulatory compliance requirements to enhance safety monitoring
Provided actionable insights on EHR integration benefits versus manual processes
Delivered hospital system differentiation analysis supporting targeted market strategies
Findings informed product development priorities and customer engagement strategies
AI-Powered Patient Subgroup Identification
Client: Global Pharmaceutical Company
Challenge: Identify specific patient populations most likely to benefit from early albumin administration across diverse pathology cohorts.
Our Approach:
Applied machine learning algorithms to large-scale EHR datasets to identify complex patient interaction patterns
Developed sophisticated data visualization tools to communicate analytical findings and support clinical decision-making
Conducted rigorous statistical validation and sensitivity analysis to ensure robustness of identified patient subgroups
Results:
Successfully identified previously unknown patient subgroups with significantly improved treatment responses
Provided evidence for targeted therapy protocols and personalized medicine approaches
Supported clinical protocol development and market segmentation strategy
Findings informed regulatory submissions and clinical guideline recommendations
Oncology Treatment Patterns & Cardiac Safety Analysis
Client: Fortune 500 Pharmaceutical Company
Challenge: Investigate treatment patterns for leukemia and lymphoma patients and identify potential cardiac adverse events associated with different therapeutic regimens.
Our Approach:
Analyzed comprehensive claims data from major healthcare databases covering billions of patient records
Applied algorithmic strategies informed by clinical expertise to identify treatment pattern variations across patient populations
Developed risk stratification models to quantify cardiac adverse event probability by treatment type
Results:
Identified significant variations in treatment patterns and associated cardiac risks
Generated actionable insights for drug safety monitoring and clinical guidelines
Supported regulatory strategy and post-market surveillance planning
Findings published in peer-reviewed literature and presented at major conferences
Market Sizing & Epidemiological Research
Client: Specialty Pharmaceutical Company
Challenge: Quantify the prevalence and healthcare resource utilization patterns for sepsis-associated acute kidney injury to support clinical trial planning and market sizing.
Our Approach:
Conducted comprehensive epidemiological analysis using large-scale EHR database with billions of patient records
Designed comparative data analysis with statistical testing and stratification of patient groups based on AKI staging and clinical definitions to assess outcomes
Applied rigorous statistical methodology to estimate disease burden and outcome patterns
Results:
Provided definitive prevalence estimates and resource utilization benchmarks
Delivered market sizing analysis that informed clinical trial design and commercial strategy
Generated real-world evidence supporting regulatory submissions and payer discussions
Enabled strategic planning for clinical development and market access initiatives
Intraoperative Hypotension Detection Algorithm
Client: Fortune 500 Medical Device Company
Challenge: Develop a novel algorithm to accurately detect intraoperative hypotension during surgery and quantify its impact on patient outcomes, healthcare costs, and resource utilization.
Our Approach:
Developed a rigorous detection algorithm based on specific clinical criteria and thresholds
Defined precise parameters for hypotension detection using duration and severity measurements
Analyzed linked EHR and claims data from multiple sources to create comprehensive patient outcome datasets with billions of records
Conducted rigorous statistical analysis to quantify relationships between hypotension episodes and downstream healthcare resource utilization and costs
Results:
Successfully developed criteria-based algorithm with high accuracy for hypotension detection
Quantified significant associations between intraoperative hypotension and increased healthcare costs and resource utilization
Provided evidence supporting product development strategy and value proposition for healthcare systems
Findings contributed to research publications and competitive positioning
Bladder Cancer Treatment Economics Study
Client: Fortune 500 Pharmaceutical Company
Challenge: Compare the economic and clinical implications of radical cystectomy versus trimodal therapy for bladder cancer treatment to inform market access strategy.
Our Approach:
Leveraged large-scale claims database to analyze real-world treatment costs, outcomes, and healthcare resource utilization
Conducted comprehensive comparative analysis across treatment modalities with statistical significance testing
Performed advanced outcome analysis using standardized grading definitions developed with clinical experts
Results:
Provided definitive evidence demonstrating cost-effectiveness and resource utilization differences between treatments
Delivered insights that directly informed pricing strategy and payer negotiation positions
Enabled data-driven market access planning and competitive differentiation
Ready to Drive Your Next Breakthrough?
These case studies represent just a sample of our work across healthcare and life sciences. Every engagement is tailored to address your specific challenges and strategic objectives.
Interested in learning more about how we can help your organization? Contact us to discuss your analytics needs and explore potential collaborations.